Wockhardt Limited
Wockhardt Limited (India) holds 30 active US FDA Type II Drug Master Files and 35 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 2 FDA-registered manufacturing sites. 16 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Wockhardt Limited: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/wockhardt-limited
Overview
Wockhardt Limited is a global pharmaceutical and biotechnology company headquartered in India. It focuses on the production and marketing of pharmaceuticals and biopharmaceutical formulations and active pharmaceutical ingredients (APIs). Wockhardt is a leader in biotechnology manufacturing and research and development.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which Wockhardt Limited holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
Wockhardt Limited holds 30 active (65 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- DESVENLAFAXINE SUCCINATE MONOHYDRATEActive2012-01-13
- PRAMIPEXOLE DIHYDROCHLORIDE USPActive2011-06-23
- CHLOROTHIAZIDE SODIUMActive2009-02-27
- ESZOPICLONEActive2008-11-03
- DONEPEZIL HYDROCHLORIDEActive2008-08-29
- DULOXETINE HYDROCHLORIDE USPActive2008-04-29
- LANSOPRAZOLE USPActive2008-04-23
- EPINEPHRINE USPActive2007-12-31
- NICARDIPINE HYDROCHLORIDEActive2007-12-31
- ZOLEDRONIC ACID MONOHYDRATEActive2007-10-31
- VALACYCLOVIR HYDROCHLORIDEActive2007-10-26
- PANTOPRAZOLE SODIUM USPActive2007-07-31
- ADENOSINE USPActive2007-05-15
- ALFUZOSIN HYDROCHLORIDEActive2007-04-06
- TAMSULOSIN HYDROCHLORIDEActive2006-12-23
- FEXOFENADINE HYDROCHLORIDEActive2006-09-29
- GRANISETRON HYDROCHLORIDEActive2006-08-21
- ZIPRASIDONE HYDROCHLORIDE MONOHYDRATEActive2006-05-30
- ENTACAPONE USPActive2006-03-01
- CLOPIDOGREL BISULFATE USP (FORM-1)Active2006-02-27
- ZOLPIDEM TARTRATEActive2006-02-27
- ANHYDROUS AZITHROMYCINActive2005-02-11
- ZONISAMIDE USPActive2005-02-07
- DIVALPROEX SODIUMActive2004-06-21
- PIOGLITAZONE HYDROCHLORIDEActive2003-08-28
- STERILE CEFTRIAXONE SODIUM USPActive2003-06-16
- CEFUROXIME AXETIL (AMORPHOUS)Active2002-11-25
- BETHANECHOL CHLORIDE USPActive2002-08-27
- DEXTROMETHORPHAN HYDROBROMIDE USPActive1996-04-18
- CAPTOPRILActive1989-04-24
- OCTREOTIDE ACETATEInactive2008-10-08
- TRANDOLAPRILInactive2006-08-26
- CYANOCOBALAMIN USPInactive2006-08-14
- RANITIDINE HYDROCHLORIDE USP (FORM II)Inactive2006-05-27
- DEXTROPROPOXYPHENE NAPSYLATE (PROPOXYPHENE NAPSYLATE USP)Inactive2005-03-18
- FLUOXETINE HYDROCHLORIDE USPInactive2005-03-15
- STERILE SODIUM CARBONATEInactive2005-02-07
- CITALOPRAM HYDROBROMIDEInactive2003-11-25
- CEFOTAXIME SODIUM (STERILE)Inactive2003-09-09
- CEFTAZIDIME FOR INJECTIONInactive2003-08-28
- CITALOPRAM HYDROBROMIDEInactive2003-08-26
- CEFUROXIME SODIUM (STERILE)Inactive2003-06-16
- METFORMIN HYDROCHLORIDEInactive2003-03-18
- AZITHROMYCIN-FORM IInactive2002-11-25
- CLARITHROMYCINInactive2002-10-30
- FEXOFENADINE HYDROCHLORIDEInactive2002-05-13
- D-OXYPHENE BASEInactive2001-06-20
- CEFUROXIME AXETIL (AMORPHOUS)Inactive2001-05-23
- CEFUROXIME AXETIL(CRYSTALLINE) USPInactive2001-05-01
- DOXAZOSIN MESYLATEInactive2001-01-16
Showing the 50 most relevant of 65 Drug Master Files (active first). The full list is in the FDA DMF list.
Registered manufacturing sites (2)
Physical sites registered with the US FDA and resolved to Wockhardt Limited, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
16 FDA enforcement records linked to this company.
- recall — Class III2018-07-18
Failed Impurities/Degradation Specifications
- recall — Class III2018-07-18
Failed Impurities/Degradation Specifications
- warning_letter2016-12-23
FDA Warning Letter (drug product)
- 4832015-03-17
Procedures not in writing, fully followed
- 4832015-03-17
Extent of discrepancy, failure investigations
- 4832015-03-17
Complaints reviewed by Quality Control Unit
- 4832015-03-17
Items to cover on annual reviews
- 4832015-03-17
Training , Education , Experience overall
- 4832015-03-17
Complaint Handling Procedure
- 4832015-03-17
Inadequate number of personnel
- 4832015-03-17
Contamination, chemical or physical change, deterioration
- 4832015-03-17
Scientifically sound laboratory controls
- 4832015-03-17
In-process samples representative, identified properly
- 4832015-03-17
Written record of complaint to include findings, follow-up
- warning_letter2013-11-25
FDA Warning Letter (drug product)
- warning_letter2013-07-18
FDA Warning Letter (drug product)
Is this Wockhardt Limited?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.